178 related articles for article (PubMed ID: 38155675)
1. Gene therapy in bestrophinopathies: Insights from preclinical studies in preparation for clinical trials.
Amato A; Wongchaisuwat N; Lamborn A; Schmidt R; Everett L; Yang P; Pennesi ME
Saudi J Ophthalmol; 2023; 37(4):287-295. PubMed ID: 38155675
[TBL] [Abstract][Full Text] [Related]
2. Bestrophin 1 and retinal disease.
Johnson AA; Guziewicz KE; Lee CJ; Kalathur RC; Pulido JS; Marmorstein LY; Marmorstein AD
Prog Retin Eye Res; 2017 May; 58():45-69. PubMed ID: 28153808
[TBL] [Abstract][Full Text] [Related]
3. BEST1 novel mutation causes Bestrophinopathies in six families with distinct phenotypic diversity.
Yang S; Li Z; Cheng W; Ma M; Qi R; Rui X; Ren Y; Sheng X; Rong W
Mol Genet Genomic Med; 2023 Jan; 11(1):e2095. PubMed ID: 36378562
[TBL] [Abstract][Full Text] [Related]
4. Distinct expression requirements and rescue strategies for
Zhao Q; Kong Y; Kittredge A; Li Y; Shen Y; Zhang Y; Tsang SH; Yang T
Elife; 2021 Jun; 10():. PubMed ID: 34061021
[TBL] [Abstract][Full Text] [Related]
5. Mutation-Dependent Pathomechanisms Determine the Phenotype in the Bestrophinopathies.
Nachtigal AL; Milenkovic A; Brandl C; Schulz HL; Duerr LMJ; Lang GE; Reiff C; Herrmann P; Kellner U; Weber BHF
Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32111077
[TBL] [Abstract][Full Text] [Related]
6. Bestrophinopathies: perspectives on clinical disease, Bestrophin-1 function and developing therapies.
Singh Grewal S; Smith JJ; Carr AF
Ther Adv Ophthalmol; 2021; 13():2515841421997191. PubMed ID: 33738427
[TBL] [Abstract][Full Text] [Related]
7. Evaluating BEST1 mutations in pluripotent stem cell-derived retinal pigment epithelial cells.
Kittredge A; Zhang Y; Yang T
Methods Enzymol; 2021; 654():365-382. PubMed ID: 34120722
[TBL] [Abstract][Full Text] [Related]
8. Small Molecules Restore Bestrophin 1 Expression and Function of Both Dominant and Recessive Bestrophinopathies in Patient-Derived Retinal Pigment Epithelium.
Liu J; Taylor RL; Baines RA; Swanton L; Freeman S; Corneo B; Patel A; Marmorstein A; Knudsen T; Black GC; Manson F
Invest Ophthalmol Vis Sci; 2020 May; 61(5):28. PubMed ID: 32421148
[TBL] [Abstract][Full Text] [Related]
9. Disease-causing mutations associated with bestrophinopathies promote apoptosis in retinal pigment epithelium cells.
Gao T; Tian C; Xu H; Tang X; Huang L; Zhao M
Graefes Arch Clin Exp Ophthalmol; 2020 Oct; 258(10):2251-2261. PubMed ID: 32507900
[TBL] [Abstract][Full Text] [Related]
10. [Mutation-Dependent Mechanisms and Their Impact on Targeted Therapeutic Strategies with Reference to Bestrophin 1 and the Bestrophinopathies].
Milenkovic A; Brandl C; Nachtigal AL; Kellner U; Weber BHF
Klin Monbl Augenheilkd; 2020 Mar; 237(3):259-266. PubMed ID: 32120431
[TBL] [Abstract][Full Text] [Related]
11. Investigation and Restoration of BEST1 Activity in Patient-derived RPEs with Dominant Mutations.
Ji C; Li Y; Kittredge A; Hopiavuori A; Ward N; Yao P; Fukuda Y; Zhang Y; Tsang SH; Yang T
Sci Rep; 2019 Dec; 9(1):19026. PubMed ID: 31836750
[TBL] [Abstract][Full Text] [Related]
12. Functional roles of bestrophins in ocular epithelia.
Marmorstein AD; Cross HE; Peachey NS
Prog Retin Eye Res; 2009 May; 28(3):206-26. PubMed ID: 19398034
[TBL] [Abstract][Full Text] [Related]
13. Bestrophin 1--Phenotypes and Functional Aspects in Bestrophinopathies.
Pasquay C; Wang LF; Lorenz B; Preising MN
Ophthalmic Genet; 2015; 36(3):193-212. PubMed ID: 24328569
[TBL] [Abstract][Full Text] [Related]
14. Bestrophin1: A Gene that Causes Many Diseases.
Smith JJ; Nommiste B; Carr AF
Adv Exp Med Biol; 2019; 1185():419-423. PubMed ID: 31884648
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of Best disease causing missense mutations on bestrophin-1 trafficking.
Johnson AA; Lee YS; Stanton JB; Yu K; Hartzell CH; Marmorstein LY; Marmorstein AD
Hum Mol Genet; 2013 Dec; 22(23):4688-97. PubMed ID: 23825107
[TBL] [Abstract][Full Text] [Related]
16. Impaired Bestrophin Channel Activity in an iPSC-RPE Model of Best Vitelliform Macular Dystrophy (BVMD) from an Early Onset Patient Carrying the P77S Dominant Mutation.
Navinés-Ferrer A; Ruiz-Nogales S; Navarro R; Pomares E
Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806438
[TBL] [Abstract][Full Text] [Related]
17. A Quantitative Chloride Channel Conductance Assay for Efficacy Testing of AAV.BEST1.
Wood SR; McClements ME; Martinez-Fernandez de la Camara C; Patrício MI; Uggenti C; Sekaran S; Barnard AR; Manson FD; MacLaren RE
Hum Gene Ther Methods; 2019 Apr; 30(2):44-52. PubMed ID: 30963787
[TBL] [Abstract][Full Text] [Related]
18.
Guziewicz KE; Cideciyan AV; Beltran WA; Komáromy AM; Dufour VL; Swider M; Iwabe S; Sumaroka A; Kendrick BT; Ruthel G; Chiodo VA; Héon E; Hauswirth WW; Jacobson SG; Aguirre GD
Proc Natl Acad Sci U S A; 2018 Mar; 115(12):E2839-E2848. PubMed ID: 29507198
[TBL] [Abstract][Full Text] [Related]
19. Tadalafil Rescues the p.M325T Mutant of Best1 Chloride Channel.
Elverson K; Warwicker J; Freeman S; Manson F
Molecules; 2023 Apr; 28(8):. PubMed ID: 37110551
[TBL] [Abstract][Full Text] [Related]
20. Bestrophin-1 influences transepithelial electrical properties and Ca2+ signaling in human retinal pigment epithelium.
Marmorstein AD; Kinnick TR; Stanton JB; Johnson AA; Lynch RM; Marmorstein LY
Mol Vis; 2015; 21():347-59. PubMed ID: 25878489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
